These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 2075125

  • 41. [Research on the activity of propaxoline in vasculopathic syndromes. II. Peripheral rheographic studies of the lower extremities].
    Rottini E, Martinelli M, Capitanucci P, De Gregorio M.
    Boll Soc Ital Biol Sper; 1967 Aug 31; 43(16):970-2. PubMed ID: 6073457
    [No Abstract] [Full Text] [Related]

  • 42. [Results of therapeutic use of plasma- and erythrocytapheresis in patients with arterial thromboobliterating diseases of the extremities].
    Litmanovich KIu, Fregatova LM, Kargin VD, Egorova LV.
    Vestn Khir Im I I Grek; 1989 Aug 31; 144(8):120-4. PubMed ID: 2603295
    [Abstract] [Full Text] [Related]

  • 43. Hemodynamic effect of cilostazol on increasing peripheral blood flow in arteriosclerosis obliterans.
    Yasuda K, Sakuma M, Tanabe T.
    Arzneimittelforschung; 1985 Aug 31; 35(7A):1198-200. PubMed ID: 4074434
    [Abstract] [Full Text] [Related]

  • 44. [Mechanisms of the positive clinical effect of plasmapheresis for arteriosclerosis obliterans in the lower extremities].
    Kliachkin ML, Osipova OV, Marchenko VB, Shesterikov IN.
    Kardiologiia; 1992 Feb 31; 32(2):68-72. PubMed ID: 1527941
    [Abstract] [Full Text] [Related]

  • 45. Therapeutic potential of atrial natriuretic peptide administration on peripheral arterial diseases.
    Park K, Itoh H, Yamahara K, Sone M, Miyashita K, Oyamada N, Sawada N, Taura D, Inuzuka M, Sonoyama T, Tsujimoto H, Fukunaga Y, Tamura N, Nakao K.
    Endocrinology; 2008 Feb 31; 149(2):483-91. PubMed ID: 17991722
    [Abstract] [Full Text] [Related]

  • 46. [Clinical efficacy of alprostan in treatment of obliterating multifocal atherosclerotic affection of arteries in patients with critical ischemia of lower extremities].
    Mishalov VG, Cherniak VA, Seliuk VM, Litvinova NIu.
    Klin Khir; 2001 Feb 31; (5):29-32. PubMed ID: 11503331
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Preliminary results of prostaglandin E1 therapy in peripheral obliterating arteriopathy].
    Pilger E, Juan H.
    Wien Klin Wochenschr; 1983 Apr 15; 95(8):263-6. PubMed ID: 6683910
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [A new method for activating the collateral circulation--revascularization osteotrepanation].
    Zusmanovich FN.
    Vestn Khir Im I I Grek; 1991 May 15; 146(5):114-5. PubMed ID: 1668417
    [No Abstract] [Full Text] [Related]

  • 54. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
    Szczeklik A, Nizankowski R, Skawinski S, Szczeklik J, Gluszko P, Gryglewski RJ.
    Lancet; 1979 May 26; 1(8126):1111-4. PubMed ID: 86835
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. [On the treatment of "intermittent claudication" in chronic peripheral obliterating arteriopathies of the lower extremities caused by arteriosclerosis and Buerger's disease].
    Seghezzi R, Pedroni G, Borri P.
    Chir Ital; 1967 May 26; 19():Suppl 2:222+. PubMed ID: 5190600
    [No Abstract] [Full Text] [Related]

  • 57. The effect of a vasodilator cocktail, administered intra-arterially and with overpressure (for a prolonged time), on the circulation of the limb.
    Solti F, Iskum M, Hartai A, Nagy J, Krasznai I.
    Cor Vasa; 1968 May 26; 10(4):287-94. PubMed ID: 4887685
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Effect of phenformin and stanozol administration on lipid metabolism in patients with occlusive vascular diseases].
    Perzanowski A, Bielawiec M, Myśliwiec M.
    Pol Tyg Lek; 1972 Jan 31; 27(5):174-6. PubMed ID: 5010762
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.